Skip to content

A comparative study of the effects of Remimazolam Tosilate and Sevoflurane on perioperative oxidative stress response in patients undergoing radical surgery for colorectal cancer

A comparative study of the effects of Remimazolam Tosilate and Sevoflurane on perioperative oxidative stress response in patients undergoing radical surgery for colorectal cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073674
Enrollment
Unknown
Registered
2023-07-18
Start date
2023-07-24
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

"Perioperative oxidative stress response in patients undergoing radical surgery for colorectal cancer."

Interventions

The sevoflurane group (S group) :"The S group received inhalational anesthesia with sevoflurane for induction and maintenance."
Remazolam group (R group):Induction and maintenance of anesthesia using remidazolam

Sponsors

The Fourth Hospital of Hebei Medical University.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: The American Society of Anesthesiologists (ASA) physical status classification of I, II, or III, anticipated surgical time of =1 hour, age between 40-80 years, no history of allergy to sedatives or analgesics, no history of anaphylactic reaction or psychiatric illness, no long-term use of sedatives or analgesics, no opioid dependence or tolerance, no bradycardia, no history of head injury, and no significant abnormalities in heart, lung, liver, or kidney function. Participants agreed to participate in this study and signed an informed consent form.

Exclusion criteria

Exclusion criteria: Patients or their relatives refuse to participate in the trial; Patients who are allergic to any component of benzodiazepine drugs or this product, patients with myasthenia gravis, schizophrenia, or severe depression; Patients who are scheduled for a second surgery during the same hospitalization; suspected malignant hyperthermia or family history of malignant hyperthermia; Patients with a Mini-Mental State Examination (MMSE) score =23 before surgery.

Design outcomes

Primary

MeasureTime frame
Catalase;Glutathione;Oxidized glutathione;Malondialdehyde;Superoxide dismutase;

Secondary

MeasureTime frame
Timely and prolonged occurrence of postoperative delirium;Length of hospitalization;

Countries

China

Contacts

Public ContactFu Jianfeng

The Fourth Hospital of Hebei Medical University.

13831128470@163.com+86 185 3111 6090

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026